|
Appointed as a Non-Executive Director in November 2000 and as Chairman in February 2006. Dr Karabelas has more than 24 years' experience in the pharmaceutical industry and is a partner at Care Capital LLC and Chairman of Human Genome Sciences, Vanda Pharmaceuticals, Inc., Inotek Pharmaceuticals Corporation and NitroMed Inc. He is also a non-executive director of Minster Pharmaceuticals plc and Renovo Group plc, as well as a member of the scientific advisory board of Epigenesis Pharmaceuticals LLC and CardioKine Inc. He was previously the CEO of Novartis Pharma AG and a nonexecutive director at Acura Pharmaceuticals Inc., Anadys Pharmaceuticals Inc., Fox Chase Cancer Centre, Halsey Pharmaceuticals, International Partnership for Microbicides, Layton Biosciences and the University of the Sciences in Philadelphia. Prior to this he spent a significant part of his career working for SmithKline Beecham plc. | 